News
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the presentation of six posters, including one oral ...
13d
YouTube on MSNPhotoshop:Create a Classic, Letterpress Portrait Poster.Photoshop CC 2020 tutorial showing how to create a portrait poster of yourself or someone you know in the style of classic, ...
Verismo Therapeutics, a clinical-stage CAR T company pioneering the KIR-CAR platform, today provided additional details on ...
today announced poster presentations on two therapeutic candidates: (1) RP04340, a potent and orally available PROTAC compound targeting KRAS G12C/D/V mutants in cancers, and (2) RP05129 ...
were selected for a poster presentation at the European Hematology Association (EHA) 2025 Congress, taking place June 12–15 in Milan, Italy. The presentation will highlight emerging safety ...
Photoshop CC 2017 tutorial showing how to place your own face into the movie poster of "The Martian". ➤ Get 15% off BORIS FX ...
today announced that the Company will give two poster presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 4–8, 2025, in Salt Lake City ...
Running a small or medium-sized business (SMB) often means juggling many roles—from marketing and customer service to HR, admin, and content creation. Luckily, AI tools can reduce much of the tedious ...
Introduction This guidance support trusts and community providers to enable front line staff to fulfil their legal requirements around the Mental Capacity Act (MCA) 2005; specifically when supporting ...
Discover 20 The Best College Graduation Party Ideas Of 2025 that will make your celebration unforgettable. Get inspired for a memorable milestone!
Skywork Launches Skywork Super Agents Globally: The "AI-Powered Office Suite" Built on Deep Research
Skywork ( unveiled Skywork Super Agents to the global market. This cutting-edge product leverages AI agent architecture and ...
Final data from the GAVRETO ® (pralsetinib) Phase 1/2 ARROW study in RET fusion-positive NSCLC and other solid tumors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results